Hexatrione Injection, Suspension
FDA Label NDC 59137-570
3 label sections · Submitted to the FDA by Medexus Pharma, Inc. · Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Medexus Pharma, Inc. for the product Hexatrione (NDC 59137-570). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dhcp page 1, dhcp p2, dhcp p3, dhcp p4, dhcp p5, dhcp p6, dhcp p7, dhcp p8, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
How Supplied
NDC 59137-570-01
- 2 mL single-dose ampoule (40 mg/2mL). One ampoule per carton.
Package Label.Principal Display Panel
20 mg/mL (2 mL Ampoule) - Ampoule Label
20 mg/mL (2 mL Ampoule) - Carton Label
* Please review the disclaimer below.